Skip to main content
. 2015 Jun 12;4(6):e001718. doi: 10.1161/JAHA.114.001718

Figure 2.

Figure 2

Acute myocardial infarction patients with heart failure or diabetes grouped by their eligibility for spironolactone in 2001, 2006, and 2011. Ideal: patients with a left ventricular ejection fraction (LVEF) ≤40% and without contraindications to spironolactone; contraindicated: patients with a contraindication (serum potassium >5 mmol/L, or serum creatinine >2.5 mg/dL [men] or >2.0 mg/dL [women], or documented allergy to spironolactone); not indicated: patients with neither indication (ie, LVEF >40%) nor contraindication to spironolactone; unknown indications: patients whose LVEF was not measured during the hospitalization.